Dyne Therapeutics Inc (NASDAQ: DYN) is -43.08% lower on its value in year-to-date trading and has touched a low of $6.36 and a high of $47.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DYN stock was last observed hovering at around $13.27 in the last trading session, with the day’s gains setting it 0.14%.
Currently trading at $13.41, the stock is 12.49% and 26.15% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.98 million and changing 1.06% at the moment leaves the stock -39.18% off its SMA200. DYN registered -57.94% loss for a year compared to 6-month loss of -56.19%. The firm has a 50-day simple moving average (SMA 50) of $10.6301 and a 200-day simple moving average (SMA200) of $22.048876.
The stock witnessed a 13.36% gain in the last 1 month and extending the period to 3 months gives it a 10.10%, and is 14.03% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.69% over the week and 5.60% over the month.
Dyne Therapeutics Inc (DYN) has around 191 employees, a market worth around $1.52B and $0.00M in sales. Distance from 52-week low is 110.85% and -71.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.42%).
The EPS is expected to shrink by -15.81% this year
282.0 institutions hold shares in Dyne Therapeutics Inc (DYN), with institutional investors hold 111.18% of the company’s shares. The shares outstanding are 113.63M, and float is at 85.23M with Short Float at 27.22%. Institutions hold 110.41% of the Float.
The top institutional shareholder in the company is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 8.02 million shares valued at $$283.03 million. The investor’s holdings represent 8.6697 of the DYN Shares outstanding. As of 2024-06-30, the second largest holder is FCPM III SERVICES B.V. with 7.85 million shares valued at $$276.86 million to account for 8.4808 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.39 million shares representing 7.9853 and valued at over $$260.69 million, while RTW INVESTMENTS, LP holds 6.9044 of the shares totaling 6.39 million with a market value of $$225.4 million.
Dyne Therapeutics Inc (DYN) Insider Activity
Still, SEC filings show that on Mar 13 ’25, Friedl-Naderer Johanna (Chief Commercial Officer) disposed off 143 shares at an average price of $12.12 for $1733.0. The insider now directly holds 96,057 shares of Dyne Therapeutics Inc (DYN).
